Because progenitor B cells make up the highest proportion of ETV6-RUNX1 positive ALL patients and may be the main cells mediating the progression of ETV6-RUNX1 ALL, progenitor B cells were refined. This evidence concerns the gene ETV6 and acute lymphoblastic leukemia.